Brief: Devyser Diagnostics Q2 EBIT Loss Widens To SEK 12.6 Mln
Aug 24 (Reuters) - Devyser Diagnostics AB DVYSR.ST :
* DEVYSER DIAGNOSTICS AB PUBLISHES INTERIM REPORT FOR THE
PERIOD,
JANUARY TO JUNE 2022
* Q2 NET SALES AMOUNTED TO SEK 30.9 MILLION (21.8)
* Q2 OPERATING PROFIT (EBIT) AMOUNTED TO SEK -12.6 MILLION
(-5.5)
* Q2 PROFIT AFTER TAX TOTALED SEK -14.3 MILLION (-6.2).
Source text for Eikon: ID:nWkrbDmsqG
Further company coverage: DVYSR.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Devyser Diagnostics AB
See all newsBrief: Devyser Awarded Tender In Italy Valued At SEK 8.9 Million
Brief: Devyser Diagnostics Appoints Niklas Axelsson As CFO
Sweden's Devyser Q1 net sales rise 12.9%, operating profit turns positive
Brief: Devyser Q1 Sales SEK 61.8 Million
Brief: Devyser Completes Cybergene Acquisition, Carries Out Compensation Share Issue